Health-related quality-of-life in treatment-naive CLL/SLL patients treated with zanubrutinib versus bendamustine plus rituximabPaolo Ghia, Mazyar Shadman, Andy H. Szeto et al.|Current Medical Research and Opinion|2023Cited by 3